Skip Navigation LinksHome > July 1, 2013 - Volume 63 - Issue 3 > Circulating Levels of Tissue Factor Microparticle Procoagula...
JAIDS Journal of Acquired Immune Deficiency Syndromes:
doi: 10.1097/QAI.0b013e3182910121
Brief Report: Clinical Science

Circulating Levels of Tissue Factor Microparticle Procoagulant Activity Are Reduced With Antiretroviral Therapy and Are Associated With Persistent Inflammation and Coagulation Activation Among HIV-Positive Patients

Baker, Jason V. MD, MS*,†; Huppler Hullsiek, Katherine PhD; Bradford, Robert L. BS§; Prosser, Rachel PhD, NP; Tracy, Russell P. PhD‖,¶; Key, Nigel S. MD§

Collapse Box


Abstract: Activation of coagulation pathways may contribute to risk for non–AIDS-related conditions among HIV-positive patients. Tissue factor (TF)–dependent procoagulant activity on circulating microparticles (MP-TF) in the plasma of 163 HIV-positive participants, both untreated and treated, with viral suppression was measured. MP-TF activity was 39% lower among treated versus untreated participants (P < 0.001), which persisted in adjusted models (−36%, P = 0.03). Among treated participants, MP-TF activity correlated modestly with D-dimer (r = 0.24, P = 0.01), von Willebrand factor (r = 0.36, P < 0.001), and interleukin-6 (r = 0.20, P = 0.04) levels. Future research should focus on mechanisms driving residual functional TF activity and whether these alterations have clinical consequences for non–AIDS-defining complications.

© 2013 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.